AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-76 Cr | ₹-26 Cr | ₹0.95 Cr | ₹46 Cr | ₹42 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of AJANTA PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-76 Cr |
| Mar2024 | ₹-26 Cr |
| Mar2023 | ₹0.95 Cr |
| Mar2022 | ₹46 Cr |
| Mar2021 | ₹42 Cr |
How is Deferred Tax Assets / Liabilities of AJANTA PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-76 Cr | Negative | |
| Mar2024 | ₹-26 Cr | Negative | |
| Mar2023 | ₹0.95 Cr | -97.95 | |
| Mar2022 | ₹46 Cr | 10.10 | |
| Mar2021 | ₹42 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹34,910.2 Cr | -2.9% | -6.7% | 3.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -2.9% |
-6.7% |
3.4% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses